Presentation by ophthalmic surgeon Mr. Konstantinos Chatzinikolas at the Afantou Junior High School event hall on the topic: “The Use of Computers and Our Eyes.
Read MoreΤηλ. Επικοινωνίας
22410-20544Stay updated with the latest developments in ophthalmology, eye care tips, and clinic news
Presentation by ophthalmic surgeon Mr. Konstantinos Chatzinikolas at the Afantou Junior High School event hall on the topic: “The Use of Computers and Our Eyes.
Read More
The DRI OCT Triton Plus is a new optical coherence tomography device with extremely high scanning speed (the only one performing 100,000 A-scans per second) and enhanced signal sensitivity in the deeper retinal layers. The system provides both two-dimensional and three-dimensional imaging capabilities.
Read More
At the recent conference held on November 14–17, 2015 in Las Vegas, Dr. Leah Makley described for the first time a sterol in the form of eye drops that has the ability to bind to the α-crystallins of the lens, helping improve the transparency and clarity of the eye’s lens, and potentially reducing the progression or even the onset of cataracts.
Read More
R-Tech Ueno has announced the completion of a Phase III clinical trial of unoprostone ophthalmic solution (an eye drop already used in the treatment of glaucoma) for the treatment of retinitis pigmentosa.
Read More
Eyeliner applied on the waterline, inside the lash line, is very likely to transfer into the eye and cause symptoms and various problems, according to a recent study that used video imaging to show mascara and makeup particles moving from the eyelid into the eye.
Read More
Dompe Pharmaceuticals, an Italian biopharmaceutical company based in L'Aquila, Italy, announced the start of a 24-week, double-blind, vehicle-controlled Phase Ib/II clinical trial to evaluate the use of rhNGF (recombinant human Nerve Growth Factor) eye drops in patients with retinitis pigmentosa.
Read More
September 9, 2025
September 9, 2025
September 9, 2025